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TECHNICAL NOTE
Novel technique of vulvo-vaginal 
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Abstract 
Background:  To describe a new surgical procedure and its results: the vulvo‑vaginal rejuvenation by lipofilling 
and an injection of combined platelet‑rich‑plasma (PRP) and hyaluronic acid (HA). Sexual life for women is affected 
by the effect of aging and by post partum traumatism. There are no standard non‑invasive treatments to offer to 
improve the trophic and dimensional alterations of the vulvo‑vaginal area. The surgical procedure consists in a 
vaginoplasty by lipofilling of the posterior vaginal wall far from the vascular axes and with an injection of an injec‑
tion of combined PRP and HA subcutaneously in the perineum. To illustrate the technique and evaluate its results, 
we present the case of a 39 year‑old‑female with history of episiotomy presented that vaginal laxity resistant to 
physical therapy. To assess the results regarding the sexual quality of life we used the modified Stabbatsberg self‑
rating scale.
Findings:  There were no intra‑operative complications with this simple procedure. During follow‑up we observed 
an improvement in the modified Stabbatsberg scale and a vulvo‑perineal rejuvenation by improving the vaginal 
trophicity and restoring a normal vaginal caliber. No post‑operative complications occurred.
Conclusions: Vulvo‑vaginal rejuvenation lipofilling and an injection of combined platelet‑rich‑plasma and hyaluronic 
acid is a minimally invasive technique that is safe and easy to perform. Further studies are necessary to assess more 
thoroughly the effectiveness and safety of this procedure and assess medium and long term results.
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Background
Aging and obstetric perineal trauma can be the cause of 
trophicity and dimensional problems such as dyspareu-
nia and vaginal laxity and leading to postpartum sexual 
dysfunction (Signorello et al. 2001). This frequent condi-
tion has a negative impact on women’s quality of life and 
sexual intercourse (Pauls et al. 2012).
Vaginal laxity mostly affects women that had no access 
to perineal rehabilitation (Harvey 2003), which is known 
to lessen the occurrence of these symptoms when per-
formed early after vaginal delivery. Colporrhaphy is a 
well-established surgical approach to treat vaginal laxity. 
And there are few non-invasive treatment options as well 
such as HA injection or fat transplantation alone.
Episiotomy sequelae such as painful scar responsible 
of dyspareunia, retractile and unaesthetic scaring are 
frequent. Studies (Eppley et  al. 2006) have shown that 
platelet-rich-plasma (PRP) promotes the wound heal-
ing process by releasing growth factors. Furthermore, 
hyaloronic acid (HA) potentiates this effect, enhances 
the hydratation of tissues and the adjunction of the HA 
to the PRP solution facilitate its use by turning it into a 
more viscous solution.
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In this article we describe our vaginoplasty technique 
which combines a vaginal lipofilling and a perineal reju-
venation consisting in injecting a solution of PRP and 
HA. We illustrate this technique with a clinical case.
Methods
Surgical technique
The patient gave her consent for the use of her personal 
and medical information, and accompanying photos in 
the publication of this case report.
The procedure is performed under general anesthesia. 
The patient is installed in a gynecologic position.
The procedure involved several steps: the isolation of 
PRP, the mixing of PRP with HA, the harvest, purification 
and injection of fat cells in the posterior vaginal wall and 
the injection of the PRP-HA preparation in the perineal 
raphe, in the vestibular fossa and in the labius minus and 
majus is they are atrophic.
The technical elements of each step are as follows:
For the PRP-HA preparation we use the RegenKit®-
BCT Cellular Matrix kit. The peripheral blood is with-
drawn from the patient and collected into three single 
use sterile tubes (4 mL per tube). Each tube contained a 
gel of HA, and inert cell-selector gel, a liquid anticoag-
ulant and allowed the preparation of 4  mL of PRP-HA 
mixture (2 mL of PRP for 2 mL of HA).
The tubes are centrifuged at 1500g for 5 min.
After centrifugation, the blood is fractionated: the red 
blood cells are trapped under the gel and cellular ele-
ments settle on the surface of the gel. The red blood cells 
depletion is the 99.7 %. The platelet concentration com-
pared to the blood flow is to 1.6 %.
HA is positioned on top of the PRP. After manual 
homogenization of the PRP with the HA, the mixture is 
withdrawn with an external sterile syringe and needle 
(Fig.  1). Concomitantly the fat is harvested according 
Coleman’s technique (Cihantimur and Herold 2013) in 
the lower abdomen area with a cannula of 3 mm, a 10 mL 
syringe (without any previous local infiltration) and was 
then centrifuged at 1500g for 1 min.
The sub-mucosal injection in the posterior vaginal wall 
and the sub-dermal injection in the perineum are per-
formed under digital control (one finger in the rectum).
The important point of this step is to avoid the prin-
cipal vascular axes of the vaginal to prevent haemato-
mas and emboli. The safest area to inject is the posterior 
wall of the vagina. The injection of the fat graft has to be 
homogenous.
The volume of fat graft injected and of the mixture of 
PRP + HA varies for every patient. Must be taken into 
account the quantity of available fat donor sites, the tol-
erance of the skin and the mucosa while injecting. We 
advice not to inject more than 30 cc of fat graft because 
of the increase risk of fat necrosis and infection in this 
area.
An antibiotic prophylaxis by amoxicilline-acid-clavu-
lanic was administrated for 48 h.
The total duration of the procedure was 30 min.
The price of the RegenKit®-BCT Cellular Matrix kit is 
off 210 euros.
Results
It is the case of a 39-year-old primiparous woman referred 
to our department for sexual dysfunction. When she was 
23, she had her only child by vaginal delivery in Africa. An 
episiotomy was performed during the delivery; no obstet-
ric forceps were used to extract the baby. No perineal 
immediate postpartum physiotherapy was performed.
The first sexual dysfunction symptoms started 7 years 
after birthdate when she resumed her sexual vaginal 
activity. Her symptoms dealt with vaginal laxity and 
included: flatus incontinence, an unpleasant feeling of a 
too wide vagina, sexual dysfunction reported by partner 
complaints of not feeling her vaginal walls, the overall 
patient’s sexual dissatisfaction and her specific conviction 
of not being able to reach orgasms. She did not notice any 
improvement of her symptoms after an intensive perineal 
physiotherapy treatment (40 sessions) that she started 
7 years after birthdate, leading to low self-confidence and 
psychological disturbance. She had no history of urinary 
or anal incontinence. Her comorbidities were a dou-
ble homozygote SC drepanocytosis, an umbilical hernia 
repair, a cholecystectomy, and an abdominal dermolipec-
tomy. She did not take any medication or hormonal con-
traception. Clinical examination showed a vaginal laxity 
with preserved vaginal tonicity, a retractile episiotomy 
scar, a slightly atrophic vaginal mucosa and a pelvic floor 
muscle laxity with a diastasis of the anus elevators. We 
did not find out any vaginal tissue defect, nor prolapse.
Fig. 1 Retreaving the PRP‑HA mixture must be done carefully and in 
sterile conditions
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During the intervention, we injected sixteen milliliters 
of purified fat cells into two linear antero-posterior trac-
tus in the posterior vaginal wall and ten milliliters of the 
PRP-HA solution in the perineum focusing in the episi-
otomy scar (Figs. 2, 3).
We used the standard and validated Stabbatsberg sex-
ual self rating scale (Garratt et al. 1995) (Fig. 4) to asses 
the repercussions of this affection in her sexual life. It 
is a standardized self-administered questionnaire that 
assesses four items: sexual interest, sexual activity, sex-
ual life and pleasure during sex. We translated it to the 
patient’s native language (French) and determinated 
a score for each item. A high score indicates a satisfac-
tory sexual life and a low score a deteriorated one. The 
pre-operatory score of the patient was 15/40, indicating a 
major negative impact on her sexual life.
No atrophy or hardening was found, nor any signs of 
infection.
The patient was allowed to resume her sexual activity at 
1-month follow-up.
At 3-month follow up, the symptoms improved sig-
nificantly. The patient was pleased with the result and 
Fig. 2 The lipofilling of the posterior vaginal wall must be performed 
under digital control to stay in the sub mucosa and avoid the risk of 
rectal injury
Fig. 3 The subcutaneous injection of the PRP‑HA solution in the 
perineum is done after fasciotomy
Fig. 4 Sabbatsberg sexual self‑rating scale
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the improvement of her sexual life. Flatus incontinence 
disappeared completely. Clinical examination showed 
a tighter vagina with a diminished vaginal caliber, an 
enhancement of vaginal mucosa trophicity, and an episi-
otomy scar softer and more hydrated. Her Stabbatsberg 
scale score was 30/40 i.e. 100 % of improvement.
Discussion
Very little literature is currently available regarding the 
minimally invasive surgical options for vulvo-vaginal 
rejuvenation and for treatment of sexual dysfunction.
Vaginal surgical tightening has been proven to have 
good aesthetic results and a patient satisfaction rate by 
Cihantimur and Herold (2013), but with the invasive 
approach of the hydrodissection of the vaginal mucosa, 
excision of portion of the posterior mucosa from vagi-
nal fornices via radiofrequency surgery and suture of the 
vaginal edges. The method we described has the advan-
tage to be a mini-invasive surgical technique.
No documented cases using the combination of theses 
three techniques are reported in the PubMed database.
Lipofilling is a popular reconstructive technique that 
uses an extemporaneous, autologous material. Fat graft-
ing using the Coleman’s technique (Coleman 2004) is 
simple, safe, reliable and time-effective, with a initial dep-
ertition of 30 % of the fat transplant and stabilization of 
the results at 3 months, which is why we decided to eval-
uate our results at 3 months after the surgery. There are 
few cases describing the use of this technique in the per-
ineal area, Zelitz et al. (2013) reported good results using 
fat grafting for the reconstruction of vaginal wall defects. 
Herold et al (2015) described a G-spot augmentation by 
injection of autologous fat in the anterior vaginal wall 
without any postoperative complications. Concerning 
our case, we were meticulous and careful with the fat 
harvest because the patient had poor donor sites. Sub-
sequently, we think that we might have injected a major 
amount of fat graft.
Hyaluronic acid is widely used in cosmetic procedures; 
this technique is mostly innocuous but several cases of 
non-thrombotic pulmonary embolism (NTP) have been 
reported Park et al. (2010).
Hyaluronic acid is a dermal filler used to cure facial 
wrinkles but its use in the vaginal sphere is very recent 
and poorly documented.
In the case reported by Park et  al. (2010) NTP was 
believed to have occurred in the systemic circulation, 
because hyaluronic acid was injected to the anterior wall 
of the vagina were there is an extensive venous plexus. 
In our case we avoided injecting this highly vascularized 
area.
A recent study by Chen et al. (2013) showed the efficiency 
and safety of HA vaginal gel to treat vaginal dryness without 
local or general complication. Regarding this results we 
hypothesize that injecting HA in the vaginal mucosa may 
directly enhance its trophicity, but further studies need to be 
carried out. Hyaluronic acid plays an important role in tis-
sue regeneration processes by facilitating the influx of many 
different types of cell into an area of damage. Bourguignon 
(2014) reported that HA interact with cell surface receptors 
such as CD44 inducing cell–cell adhesions, cell substrate 
adhesions, cell proliferation and cell migration.
PRP contains growth factors as PDGF, TGF-B, IGF, EGF, 
VEGF released by platelets that have an important role in 
inflammation reduction, angiogenesis stimulation, and 
collagen III synthesis (Eppley et al. 2006). Several studies 
have shown a beneficial effect of the PRP on wound heal-
ing. Hua et al (2012) reported promising results with PRP 
in the gynecological sphere to cure symptomatic cervical 
ectopy. We believe that mixing PRP with hyaluronic acid 
potentialize its effect by facilitating the integration of the 
filler in surrounding tissues, and easing the healing pro-
cess. Nevertheless as Kushida et al. (2014) showed in their 
comparative study of eight PRP separation system (not 
including any Regen Lab kit), they vary widely in terms 
of platelet, white blood cell, red blood cell, growth fac-
tor, platelet-derived growth factor, transforming growth 
factor beta-1 and vascular endothelial growth factor. The 
total dose of platelets for 2 mL of PRP prepared with the 
RegenKit®-BCT Cellular Matrix kit was of 0.9 billion and 
the obtained concentration of growth factor is as follows: 
TGF-beta: 67.37  ng/mL, PFGF-AB: 12.71  ng/mL, bFGF: 
0,06 ng/mL, IGF: 82.22 ng/mL, VEGF: 0.87 ng/mL, EGF: 
0.93 ng/mL (data on file).
Our results are encouraging. The benefit of this proce-
dure seems to be on the mechanical aspect of the sexual 
dysfunction as incontinence flatus. The improvement of 
global sexual life quality is supported by a simple, accept-
able, valid, and reliable scale.
We assume that anonymity in that kind of question-
naire will be more objective however we do not believe 
that the patient retained information; she was very coop-
erative. Concerning the absence of vaginal orgasm, we 
have to bear in mind the high subjectivity of this matter. 
We did not take into account the other factors that might 
influence sexual life quality as depression, fatigue, part-
ner expertise, etc.
Conclusion
The vaginoplasty with lipofilling technique is a simple 
mini-invasive method that is not currently described in 
the literature. We wanted to share our experience in that 
domain and illustrate its efficiency and safety.
We believe that the combined injection of PRP and HA 
technique should be considered part of the therapeutic 
armamentarium used for perineal rejuvenation as well.
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Although we didn’t test for it we believe this technique 
will also other perineal aging consequences as vaginal 
dryness and vulvary pain. It is important to emphasize 
that a multidisciplinary approach is essential to asses 
before surgery the anatomical implication of the sexual 
dysfunction that will respond to surgical treatment and 
the psychosocial, relational and sexological aspects that 
need specific treatment.
We recognize the limitations of a single-subject presen-
tation, but our results encouraged us to share our expe-
rience without any delay. A multicenter clinical trial is 
necessary to described more thoroughly the effectiveness 
and safety of this technique and the stability of the results 
in the medium and long term, we are at the disposal of 
any interested team.
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